Linn, A., Boton, N., Beekmann, S. E., Kociolek, L., Sandora, T. J., Polgreen, P. M., Lee, M. S. L., & Mehrotra, P. (2026). Pediatric Infectious Diseases Physicians’ Preferences for Management of Clostridioides difficile Infection: An Emerging Infections Network Survey.. Journal of the Pediatric Infectious Diseases Society, 15(1).
Abstract
We queried pediatric infectious diseases physicians via the Emerging Infections Network regarding management preferences for Clostridioides difficile infection (CDI). We explored use of vancomycin, fidaxomicin, bezlotoxumab, and fecal microbiota transplantation and found that physicians are increasingly considering newer and adjunctive therapies for pediatric CDI, highlighting the need for updated guidelines.